Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00117468 · ClinicalTrials.gov registry record · Phase 2
Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement
A Phase 2 study, sponsored by Duramed Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT00117468 is a Phase 2 study that has completed, run by Duramed Research. The registered enrollment target is 20 participants.
The verdict
NCT00117468, a Phase 2 study, has completed, sponsored by Duramed Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a single-center, open-label, randomized, active-controlled study to compare DR-2011 to progesterone vaginal gel for luteal phase replacement.
Interventions
- DRUG DR-2011
- DRUG Progesterone 8% Vaginal Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00117468
The ClinicalTrials.gov registry entry for NCT00117468 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duramed Research, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which DR-2011 is the first listed.
NCT00117468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00117468 about?
NCT00117468 is a clinical study titled "Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement". This is a single-center, open-label, randomized, active-controlled study to compare DR-2011 to progesterone vaginal gel for luteal phase replacement.
What is the current status of trial NCT00117468?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2005-06. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00117468?
The interventions under investigation include: DR-2011 (DRUG), Progesterone 8% Vaginal Gel (DRUG).
Who is sponsoring clinical trial NCT00117468?
This trial is sponsored by Duramed Research, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.